These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1133 related items for PubMed ID: 8819121

  • 1. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.
    Benathan M.
    Melanoma Res; 1996 Jun; 6(3):183-9. PubMed ID: 8819121
    [Abstract] [Full Text] [Related]

  • 2. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
    Benathan M, Virador V, Furumura M, Kobayashi N, Panizzon RG, Hearing VJ.
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
    [Abstract] [Full Text] [Related]

  • 3. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
    Benathan M, Alvero-Jackson H, Mooy AM, Scaletta C, Frenk E.
    Melanoma Res; 1992 Dec; 2(5-6):305-14. PubMed ID: 1337997
    [Abstract] [Full Text] [Related]

  • 4. Opposite regulation of tyrosinase and glutathione peroxidase by intracellular thiols in human melanoma cells.
    Benathan M.
    Arch Dermatol Res; 1997 May; 289(6):341-6. PubMed ID: 9209680
    [Abstract] [Full Text] [Related]

  • 5. Cysteine-dependent 5-S-cysteinyldopa formation and its regulation by glutathione in normal epidermal melanocytes.
    Benathan M, Labidi F.
    Arch Dermatol Res; 1996 Oct; 288(11):697-702. PubMed ID: 8931873
    [Abstract] [Full Text] [Related]

  • 6. gamma-Glutamyl transpeptidase, tyrosinase, and 5-S-cysteinyldopa production in melanoma cells.
    Mojamdar M, Ichihashi M, Mishima Y.
    J Invest Dermatol; 1983 Aug; 81(2):119-21. PubMed ID: 6135733
    [Abstract] [Full Text] [Related]

  • 7. Glutathione efflux associated with a low gamma-glutamyl transpeptidase activity in human melanoma cells.
    Benathan M.
    Br J Dermatol; 1997 Nov; 137(5):721-7. PubMed ID: 9415231
    [Abstract] [Full Text] [Related]

  • 8. Insulin inhibits tyrosinase activity and 5-S-cysteinyldopa formation in human melanoma cells.
    Benathan M, Labidi F.
    Acta Derm Venereol; 1997 Jul; 77(4):281-4. PubMed ID: 9228219
    [Abstract] [Full Text] [Related]

  • 9. Effect of dopa-loading on glutathione metabolising enzymes and tyrosinase in relation to 5-S-cysteinyl-dopa genesis in cultured B-16 melanoma cells.
    Chakraborty AK, Ichihashi M, Mishima Y.
    J Dermatol Sci; 1991 Sep; 2(5):329-35. PubMed ID: 1683790
    [Abstract] [Full Text] [Related]

  • 10. Melanin-related biochemistry of IGR 1 human melanoma cells.
    Karg E, Odh G, Rosengren E, Wittbjer A, Rorsman H.
    Melanoma Res; 1991 Sep; 1(1):5-13. PubMed ID: 1822769
    [Abstract] [Full Text] [Related]

  • 11. Effect of DOPA-loading on glutathione-dependent 5-S-cysteinyldopa genesis in melanoma cells in vitro.
    Mojamdar M, Ichihashi M, Mishima Y.
    J Invest Dermatol; 1982 Mar; 78(3):224-6. PubMed ID: 6799583
    [Abstract] [Full Text] [Related]

  • 12. Effects on interstitial glutathione, cysteine and 5-S-cysteinyldopa of buthionine sulphoximine in human melanoma transplants.
    Dizdar N, Kullman A, Kågedal B, Arstrand K.
    Melanoma Res; 1997 Aug; 7(4):322-8. PubMed ID: 9293482
    [Abstract] [Full Text] [Related]

  • 13. Glutathione depletion increases tyrosinase activity in human melanoma cells.
    del Marmol V, Solano F, Sels A, Huez G, Libert A, Lejeune F, Ghanem G.
    J Invest Dermatol; 1993 Dec; 101(6):871-4. PubMed ID: 7902381
    [Abstract] [Full Text] [Related]

  • 14. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S, Jimbow K, Kato T, Kiyota M, Fujita K.
    Acta Derm Venereol; 1983 Dec; 63(6):463-7. PubMed ID: 6198833
    [Abstract] [Full Text] [Related]

  • 15. Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice.
    Dizdar N, Kullman A, Kågedal B.
    Cancer Chemother Pharmacol; 2000 Dec; 45(3):192-8. PubMed ID: 10663636
    [Abstract] [Full Text] [Related]

  • 16. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
    Prezioso JA, Damodaran KM, Wang N, Bloomer WD.
    Biochem Pharmacol; 1993 Jan 26; 45(2):473-81. PubMed ID: 8435097
    [Abstract] [Full Text] [Related]

  • 17. The effect of cysteine on oxidation of tyrosine, dopa, and cysteinyldopas.
    Agrup G, Hansson C, Rorsman H, Rosengren E.
    Arch Dermatol Res; 1982 Jan 26; 272(1-2):103-15. PubMed ID: 6819815
    [Abstract] [Full Text] [Related]

  • 18. Dopaquinone addition products in cultured human melanoma cells.
    Carstam R, Hansson C, Lindbladh C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1987 Jan 26; 67(2):100-5. PubMed ID: 2438872
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of 5-S-glutathionyldopa.
    Carstam R, Edner C, Hansson C, Lindbladh C, Rorsman H, Rosengren E.
    Acta Derm Venereol Suppl (Stockh); 1986 Jan 26; 126():1-12. PubMed ID: 3103358
    [Abstract] [Full Text] [Related]

  • 20. Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells.
    Prezioso JA, Fitzgerald GB, Wick MM.
    Pigment Cell Res; 1990 Jan 26; 3(2):49-54. PubMed ID: 2117268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.